Barnas U, Mayer G
Department of Internal Medicine III, University of Vienna, Austria.
Kidney Int Suppl. 1997 Dec;63:S78-80.
Proteinuria in chronic kidney transplant failure (CKTF) is due to an alteration of glomerular permselectivity and two major determinants can be characterized experimentally: (1) size selectivity, that is, the ability of the glomerular filter to progressively hinder the passage of macromolecules with increasing molecular radius and (2) charge selectivity, the ability to restrict filtration of negatively charged molecules more effectively than that of equally sized uncharged or cationic compounds. The fractional clearance values of neutral polydisperse dextran molecules create a sieving profile to describe size selectivity, and anionic dextransulfate is used to evaluate charge selectivity. We characterized permselectivity in renal transplants recipients with various degrees of proteinuria. Proteinuria < 1 g/day is caused by an isolated defect of glomerular charge selectivity, whereas nephrotic range proteinuria (characterized histologically by transplant glomerulopathy) is due to an additional impairment of glomerular size selectivity. This sequence is similar to the one observed in patients with chronic native kidney disease (such as diabetic nephropathy). It therefore can be speculated that therapeutic interventions which have been shown to reduce proteinuria in patients with chronic native kidney disease will also beneficially affect permselectivity in CKTF.
慢性肾移植失败(CKTF)中的蛋白尿是由于肾小球滤过屏障选择性的改变,实验上可确定两个主要决定因素:(1)大小选择性,即肾小球滤过器随着分子半径增加而逐渐阻碍大分子通过的能力;(2)电荷选择性,即比同等大小的不带电或阳离子化合物更有效地限制带负电荷分子滤过的能力。中性多分散葡聚糖分子的分数清除值可形成筛分曲线来描述大小选择性,而阴离子葡聚糖硫酸酯则用于评估电荷选择性。我们对不同程度蛋白尿的肾移植受者的滤过屏障选择性进行了特征描述。蛋白尿<1g/天是由肾小球电荷选择性的孤立缺陷引起的,而肾病范围蛋白尿(组织学特征为移植肾小球病)是由于肾小球大小选择性的额外损害所致。这一顺序与慢性原发性肾病(如糖尿病肾病)患者中观察到的顺序相似。因此可以推测,已证明能降低慢性原发性肾病患者蛋白尿的治疗干预措施也将对CKTF的滤过屏障选择性产生有益影响。